Methylbutyltryptamine
chemical compound
Methylbutyltryptamine (MBT), also known as N-methyl-N-butyltryptamine, is a lesser-known psychedelic drug of the tryptamine family related to dimethyltryptamine (DMT).
Use and effects
In his book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose of MBT as 250 to 400 mg orally and the duration as 4 to 6 hours. MBT produces a heavy body load with dehydration, and causes visuals similar to those of DMT. Very little data exists about the pharmacological properties, metabolism, and toxicity of MBT.
Interactions
Chemistry
Synthesis
The chemical synthesis of MBT has been described.
Analogues
Analogues of MBT include 4-HO-MBT, 5-MeO-MBT, methylethyltryptamine (MET), methylpropyltryptamine (MPT), methylisopropyltryptamine (MiPT), methylallyltryptamine (MALT), among others.
MSBT
TiHKAL mentions that a structural isomer of MBT exists, with the butyl group attached at the nitrogen atom. It is known as N-sec-butyl-N-methyltryptamine, or MSBT. However, little is known about its psychoactivity.
This brief starts where responsible research should: with the source description of “Methylbutyltryptamine” as chemical compound. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the science & nature register because the source frames it as chemical compound. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Datasets, specimens, observations and peer-reviewed methods provide the appropriate test for the technical claims summarized here. The source revision retrieved here is dated May 17, 2026. The linked authority identifier is Q6823964. None of the 0 selected statements returned an explicit reference.
Scientific names, classifications and consensus can change while older terminology persists in catalogues and historical literature. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “Methylbutyltryptamine”, its source revision and the description used here.
- Expand the search: follow Methylbutyltryptamine primary sources, Methylbutyltryptamine archive and Methylbutyltryptamine research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Methylbutyltryptamine”?
- Is the terminology current, historical or disputed?
- Which observation, specimen, dataset or publication supports the account?
Search terms from this dossier
This entry incorporates text from “Methylbutyltryptamine” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.